SUSMED Co., Ltd. announced a private placement of non convertible preferred shares on May 11, 2020. The investment ratio is expected to be about 2.5-3.0% of the total number of issued shares. The transaction will include participation from new investor Suzuken Co., Ltd. (TSE:9987).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
534 JPY | +0.56% | +1.33% | -60.00% |
2023 | SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index | CI |
2022 | Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.00% | 5.65Cr | |
-14.06% | 19TCr | |
+1.48% | 17TCr | |
+4.30% | 16TCr | |
+7.01% | 10TCr | |
+13.18% | 8.28TCr | |
+38.26% | 8.28TCr | |
-5.04% | 7.32TCr | |
-21.04% | 5.18TCr | |
-8.25% | 4.4TCr |
- Stock Market
- Equities
- 4263 Stock
- News SUSMED,Inc.
- SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.